We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

TARDBP rs80356739: What Your Genotype Means

rs80356739
Health Predisposition
Moderate evidenceGene: TARDBP

The rs80356739 variant is a specific genetic change located within the TARDBP gene. It has been identified in clinical research as a pathogenic variant associated with the development of Amyotrophic lateral sclerosis type 10 (ALS10).

What each genotype means

C/CLower attention

Typical risk profile

This is the common, wild-type genotype for this position in the TARDBP gene. It is not associated with the increased risk of Amyotrophic lateral sclerosis type 10 linked to this specific variant.

This is the most common genotype found in the general population.

C/GHigher attention

Potential risk carrier

This genotype indicates you carry one copy of the G allele, which is classified as pathogenic in clinical databases regarding Amyotrophic lateral sclerosis type 10. Because this condition can follow an autosomal dominant pattern, you should consult with a genetic counselor or neurologist to understand the clinical significance of this finding for your personal health.

This genotype is rare in the general population.

G/GHigher attention

Increased risk profile

This genotype indicates you carry two copies of the G allele, which is identified as a pathogenic variant linked to Amyotrophic lateral sclerosis type 10. It is important to discuss these results with a medical professional or genetic specialist to determine appropriate clinical follow-up and to understand the implications for your health.

This genotype is extremely rare in the general population.

Understanding the Variant and Its Location

The variant rs80356739 is a single nucleotide polymorphism (SNP) located on chromosome 1 within the TARDBP gene. In genetic databases, this specific change is often documented as a C to G substitution (C>G). The TARDBP gene provides instructions for creating a protein called TDP-43, which plays a critical role in how cells process RNA. Because this variant is located within a gene essential for neuronal health, researchers monitor it closely to understand how structural changes in the DNA sequence might influence protein function. Genetic variants like this are identified through high-throughput sequencing technologies that allow scientists to pinpoint exact locations on the human genome where a single letter of the genetic code differs between individuals.

The Role of the TARDBP Gene

The TARDBP gene encodes the TDP-43 protein, which is vital for the regulation of RNA splicing and stability. This protein is involved in many cellular processes, including the survival of neurons. Under normal conditions, TDP-43 is primarily found in the cell nucleus. However, in certain disease states, the protein can misfold, aggregate, and accumulate in the cytoplasm of cells, forming toxic clumps. This process is a hallmark of several neurodegenerative conditions. When mutations occur in the TARDBP gene, they can disrupt the normal function of TDP-43, leading to a loss of its protective roles or a gain of toxic properties that damage motor neurons. Understanding this gene is central to modern research into the mechanisms of motor neuron diseases.

Research Associations and Evidence Strength

The rs80356739 variant is classified in clinical databases, such as ClinVar, as a pathogenic variant linked to Amyotrophic lateral sclerosis type 10 (ALS10). ALS10 is a form of motor neuron disease characterized by the progressive degeneration of upper and lower motor neurons, leading to muscle weakness and paralysis. The evidence linking this specific variant to the condition is considered significant in the context of clinical genetics. However, it is important to note that ALS is a complex, heterogeneous condition. While specific mutations in TARDBP can be causative, the disease often exhibits incomplete penetrance, meaning that not everyone who carries a pathogenic variant will necessarily develop the disease. Research continues to explore how this variant interacts with other genetic and environmental factors to influence disease onset and progression.

Population Frequency and Genetic Context

Information regarding the population frequency of rs80356739 is limited in large-scale public databases. Because this variant is associated with a rare, severe neurodegenerative condition, it is not typically found at high frequencies in the general population. Most individuals do not carry this specific mutation. Genetic studies often focus on families with a history of ALS to identify such variants, rather than screening the general public. Because there is no widely recorded frequency data across diverse ancestral groups, it is difficult to estimate how common this variant is globally. The absence of frequency data in standard population catalogs is common for rare, disease-causing variants, as they are generally excluded from the healthy population gene pool.

What This Information Means for You

If you have received information about this variant, it is important to understand that genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or a neurologist. A finding of a pathogenic variant does not constitute a medical diagnosis, nor does it guarantee that an individual will develop a specific condition. ALS is a complex disease, and the presence of a single variant is only one piece of a much larger biological puzzle. You cannot use this information to self-diagnose or predict future health outcomes without clinical context. If you are concerned about your genetic risk or family history, please consult with a medical professional who can provide appropriate testing, clinical evaluation, and guidance based on your personal health history.

How common is this variant?

There is no widely recorded population frequency for this variant in major public databases, as it is a rare, disease-associated mutation.

Frequently asked questions

What is Amyotrophic lateral sclerosis type 10?

ALS10 is a specific, genetically defined form of Amyotrophic lateral sclerosis caused by mutations in the TARDBP gene. It leads to the progressive loss of motor neurons, resulting in muscle weakness and paralysis.

Does having this variant mean I will get ALS?

Not necessarily. While this variant is associated with ALS10, the disease can show incomplete penetrance, meaning not all carriers develop symptoms. Clinical diagnosis requires a comprehensive evaluation by a neurologist.

Where can I get tested for this variant?

Genetic testing for specific variants is typically ordered by a physician or genetic counselor after a clinical assessment. It is not recommended to pursue such testing without professional medical guidance.

Is there a cure for ALS10?

Currently, there is no cure for ALS10. Research is ongoing to understand the underlying mechanisms of TDP-43 proteinopathy and to develop potential therapeutic interventions.

Sources & further reading

Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs80356739?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in TARDBP